The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The price of Molina Healthcare Inc (NYSE: MOH) closed at $166.54 in the last session, up 1.03% from day before closing price of $164.84. In other words, the price has increased by $1.03 from its previous closing price. On the day, 0.75 million shares were traded. MOH stock price reached its highest trading level at $166.72 during the session, while it also had its lowest trading level at $164.25.
Ratios:
We take a closer look at MOH’s different ratios to gain a better understanding of the stock. In the meantime, Its Debt-to-Equity ratio is 0.92 whereas as Long-Term Debt/Eq ratio is at 0.92.
On October 16, 2025, TD Cowen Downgraded its rating to Hold which previously was Buy but kept the price unchanged to $203.
On October 14, 2025, Goldman started tracking the stock assigning a Neutral rating and target price of $207.Goldman initiated its Neutral rating on October 14, 2025, with a $207 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 24 ’25 when Schapiro Richard M sold 357 shares for $143.02 per share. The transaction valued at 51,058 led to the insider holds 11,352 shares of the business.
Schapiro Richard M bought 357 shares of MOH for $50,536 on Nov 24 ’25. On Aug 06 ’25, another insider, ROMNEY RONNA, who serves as the Director of the company, sold 700 shares for $153.74 each. As a result, the insider received 107,618 and left with 17,131 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MOH now has a Market Capitalization of 9026467840 and an Enterprise Value of 3965156096. As of this moment, Molina’s Price-to-Earnings (P/E) ratio for their current fiscal year is 10.32, and their Forward P/E ratio for the next fiscal year is 12.14. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.19 while its Price-to-Book (P/B) ratio in mrq is 2.03. Its current Enterprise Value per Revenue stands at 0.093 whereas that against EBITDA is 2.721.
Stock Price History:
The Beta on a monthly basis for MOH is 0.51, which has changed by -0.43363684 over the last 52 weeks, in comparison to a change of 0.17823458 over the same period for the S&P500. Over the past 52 weeks, MOH has reached a high of $359.97, while it has fallen to a 52-week low of $133.40. The 50-Day Moving Average of the stock is 6.55%, while the 200-Day Moving Average is calculated to be -26.36%.
Shares Statistics:
According to the various share statistics, MOH traded on average about 1.64M shares per day over the past 3-months and 1345480 shares per day over the past 10 days. A total of 51.00M shares are outstanding, with a floating share count of 50.79M. Insiders hold about 1.20% of the company’s shares, while institutions hold 113.24% stake in the company. Shares short for MOH as of 1765756800 were 3621816 with a Short Ratio of 2.21, compared to 1763078400 on 3856991. Therefore, it implies a Short% of Shares Outstanding of 3621816 and a Short% of Float of 9.379999999999999.
Earnings Estimates
. The current market rating for Molina Healthcare Inc (MOH) reflects the collective analysis of 17.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $4.68, with high estimates of $6.11 and low estimates of $4.68.
Analysts are recommending an EPS of between $14.26 and $13.34 for the fiscal current year, implying an average EPS of $13.92. EPS for the following year is $16.44, with 18.0 analysts recommending between $16.44 and $16.44.
Revenue Estimates
According to 12 analysts,. The current quarter’s revenue is expected to be $11.29B. It ranges from a high estimate of $11.29B to a low estimate of $11.29B. As of. The current estimate, Molina Healthcare Inc’s year-ago sales were $10.5BFor the next quarter, 12 analysts are estimating revenue of $11.76B. There is a high estimate of $12.19B for the next quarter, whereas the lowest estimate is $11.76B.
A total of 15 analysts have provided revenue estimates for MOH’s current fiscal year. The highest revenue estimate was $45.51B, while the lowest revenue estimate was $45.34B, resulting in an average revenue estimate of $45.34B. In the same quarter a year ago, actual revenue was $40.65BBased on 15 analysts’ estimates, the company’s revenue will be $47.33B in the next fiscal year. The high estimate is $48.42B and the low estimate is $47.33B.
